CADL vs. CRBP

Last updated Jun 4, 2026

CADL (Candel Therapeutics, Inc.) and CRBP (Corbus Pharmaceuticals Holdings, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, CADL returned 79.17%/yr vs -9.17%/yr for CRBP. At a 0.17 correlation, their price movements are largely independent.

Performance

CADL vs. CRBP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Candel Therapeutics, Inc. (CADL) and Corbus Pharmaceuticals Holdings, Inc. (CRBP). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CADL achieves a 55.75% return, which is significantly higher than CRBP's -9.34% return.

CADL

• 1D: 4.51%
• 1M: 16.87%
• YTD: 55.75%
• 6M: 75.30%
• 1Y: 53.04%
• 3Y*: 79.17%
• 5Y*: —
• 10Y*: —

CRBP

• 1D: -2.12%
• 1M: -29.85%
• YTD: -9.34%
• 6M: -30.83%
• 1Y: -11.08%
• 3Y*: -9.17%
• 5Y*: -34.10%
• 10Y*: -23.85%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CADL vs. CRBP - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CADL Candel Therapeutics, Inc.	55.75%	-34.91%	490.48%	-17.88%	-77.11%	11.71%
CRBP Corbus Pharmaceuticals Holdings, Inc.	-9.34%	-31.02%	95.36%	82.20%	-82.05%	-55.71%

Correlation

The correlation between CADL and CRBP is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.34
Correlation (3Y) Calculated over the trailing 3-year period	0.23
Correlation (All Time) Calculated using the full available price history since Jul 28, 2021	0.17

The correlation between CADL and CRBP shifts across timeframes, from 0.17 (all time) to 0.34 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap CADL : $548.78M CRBP : $138.05M
EPS CADL : -$0.97 CRBP : -$5.98
PB Ratio CADL : 3.98 CRBP : 1.09
Total Revenue (TTM) CADL : $0.00 CRBP : $0.00
Gross Profit (TTM) CADL : -$600.00K CRBP : -$149.00K
EBITDA (TTM) CADL : -$71.64M CRBP : -$61.36M

Return for Risk

CADL vs. CRBP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CADL

CADL Risk / Return Rank: 65
CADL Sharpe Ratio Rank: 64
CADL Sortino Ratio Rank: 66
CADL Omega Ratio Rank: 63
CADL Calmar Ratio Rank: 68
CADL Martin Ratio Rank: 63

CRBP

CRBP Risk / Return Rank: 37
CRBP Sharpe Ratio Rank: 35
CRBP Sortino Ratio Rank: 39
CRBP Omega Ratio Rank: 40
CRBP Calmar Ratio Rank: 35
CRBP Martin Ratio Rank: 35

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CADL vs. CRBP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Candel Therapeutics, Inc. (CADL) and Corbus Pharmaceuticals Holdings, Inc. (CRBP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CADL	CRBP	Difference
Sharpe ratio Return per unit of total volatility	0.73	-0.14	+0.87
Sortino ratio Return per unit of downside risk	1.55	0.38	+1.17
Omega ratio Gain probability vs. loss probability	1.18	1.05	+0.13
Calmar ratio Return relative to maximum drawdown	1.44	-0.18	+1.62
Martin ratio Return relative to average drawdown	2.54	-0.28	+2.81
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CADL vs. CRBP - Sharpe Ratio Comparison

The current CADL Sharpe Ratio is 0.73, which is higher than the CRBP Sharpe Ratio of -0.14. The chart below compares the historical Sharpe Ratios of CADL and CRBP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CADL	CRBP	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.73	-0.14	+0.87
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.22	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.19	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.03	-0.15	+0.18

Drawdowns

CADL vs. CRBP - Drawdown Comparison

The maximum CADL drawdown since its inception was -94.33%, smaller than the maximum CRBP drawdown of -99.31%. Use the drawdown chart below to compare losses from any high point for CADL and CRBP.

Drawdown Indicators

	CADL	CRBP	Difference
Max Drawdown Largest peak-to-trough decline	-94.33%	-99.31%	+4.98%
Max Drawdown (1Y) Largest decline over 1 year	-37.04%	-61.88%	+24.84%
Max Drawdown (3Y) Largest decline over 3 years	-72.86%	-92.01%	+19.15%
Max Drawdown (5Y) Largest decline over 5 years	—	-96.77%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-99.31%	—
Current Drawdown Current decline from peak	-37.14%	-97.62%	+60.48%
Average Drawdown Average peak-to-trough decline	-62.79%	-66.00%	+3.21%
Ulcer Index Depth and duration of drawdowns from previous peaks	20.98%	39.98%	-19.00%

Volatility

CADL vs. CRBP - Volatility Comparison

The current volatility for Candel Therapeutics, Inc. (CADL) is 16.28%, while Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a volatility of 44.74%. This indicates that CADL experiences smaller price fluctuations and is considered to be less risky than CRBP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CADL	CRBP	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.28%	44.74%	-28.46%
Volatility (6M) Calculated over the trailing 6-month period	53.92%	60.55%	-6.63%
Volatility (1Y) Calculated over the trailing 1-year period	72.87%	82.11%	-9.24%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	167.21%	159.14%	+8.07%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	167.21%	129.09%	+38.12%

Dividends

CADL vs. CRBP - Dividend Comparison

Neither CADL nor CRBP has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both CADL and CRBP in my portfolio?

CADL and CRBP have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CADL or CRBP?

CRBP has higher volatility (44.74%) compared to CADL (16.28%). In terms of maximum drawdown, CADL dropped -94.33% vs CRBP's -99.31%.

Which has better risk-adjusted returns?

CADL currently has the higher Sharpe Ratio (0.73 vs -0.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.